New stable and specific mimics of T cell epitopes for tumor immunotherapy

  • Perlmutter, Patrick (Primary Chief Investigator (PCI))
  • Aguilar, Mibel (Chief Investigator (CI))
  • Purcell, Anthony (Chief Investigator (CI))

Project: Research

Project Details

Project Description

The major aim of this project is to develop specifically designed peptides for use as vaccines in cancer. The significance of this work lies in the potential to protect animals and humans from a wide variety of cancers through treatment with relatively cheap, readily prepared small peptides. Ciritical to the success of this approach is our teachnology which stabilises these peptides against degradation in the body whilst maintaining their high level of potency.
StatusFinished
Effective start/end date6/12/063/06/08

Funding

  • Australian Research Council (ARC): AUD335,625.00
  • Australian Research Council (ARC): AUD335,625.00
  • Australian Research Council (ARC): AUD437,500.00
  • Cancer Therapeutics Limited: AUD1,028,011.89
  • Cancer Therapeutics Limited: AUD531,837.89
  • Cancer Therapeutics Limited: AUD350,084.98
  • University of Melbourne
  • University of Melbourne